A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2001
11/15/2001	CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001	CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001	CA2409729A1 5-ht7 receptor antagonists
11/15/2001	CA2409720A1 A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
11/15/2001	CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	CA2408665A1 Novel regulator of g protein signalling
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	CA2408448A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001	CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408293A1 Novel vitronectin receptor antagonists
11/15/2001	CA2408290A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	CA2408228A1 Method for promoting neovascularization
11/15/2001	CA2408220A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001	CA2408097A1 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407864A1 Lipid metabolism enzymes
11/15/2001	CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001	CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001	CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	CA2404987A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/15/2001	CA2395314A1 Compounds and methods for modulating cerebral amyloid angiopathy
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153302A1 Diagnostics and therapeutics for macular degeneration
11/14/2001	EP1153301A1 Diagnostics and therapeutics for arterial wall disruptive disorders
11/14/2001	EP1153129A1 Method of treating restenosis by antisense targeting of c-myc
11/14/2001	EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001	EP1153035A2 Human lipid-associated proteins
11/14/2001	EP1153033A1 Method for purifying a red fruit extract containing anthocyanosides
11/14/2001	EP1153014A2 Beta-alanine derivatives
11/14/2001	EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001	EP1152764A1 Compositions and methods for use in targeting vascular destruction
11/14/2001	EP1152755A1 Essential fatty acids in the prevention of cardiovascular events
11/14/2001	EP1152752A1 Methods for preventing graft rejection and ischemia-reperfusion injury
11/14/2001	EP1152750A1 Spontaneously dispersible n-benzoyl staurosporine compositions
11/14/2001	EP0832077B1 Improved isoxazoline fibrinogen receptor antagonists
11/14/2001	EP0799052B1 New antithrombotic formulation, process for its manufacturing, and use thereof
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322212A Neuropeptide Y agaonists
11/14/2001	CN1322205A Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
11/14/2001	CN1322202A Quinazoline derivatives
11/14/2001	CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1322143A Gene therapy for cerebrovasclar disorders
11/14/2001	CN1322137A Use of GLP-1 or analogs in treatment of stroke
11/14/2001	CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322133A Vitronectin receptor antagonists
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321638A Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321486A Yinkang lotion
11/14/2001	CN1321484A Medicine for curing coronary heart disease with hypertension and its preparation process
11/14/2001	CN1074673C Freeze-dried kakonein powder injection and preparing method thereof
11/14/2001	CN1074672C Method for preparing fermented soya beans and ginger injection
11/13/2001	US6316648 Purified 5,6,15-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid; anticarcinogenic and antiproliferative agents
11/13/2001	US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
11/13/2001	US6316634 Method for preparing cycloheptimidazoles
11/13/2001	US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001	US6316504 Administering r(+)-n-propargyl-1-aminoindan or its salt for therapy of multiple sclerosis
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316502 Administering disulfide derivative of dithiocarbamate compound to bind to iron
11/13/2001	US6316501 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
11/13/2001	US6316487 For therapy of ventricular tachyarrhythmias, especially in patients with congestive heart failure and ventricular arrhythmias and supraventricular arrhythmias, including atrial fibrillation and re-entrant tachyarrhythmias
11/13/2001	US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316475 Treatment of cancer, asthma, heart diseases, seizures, inflammation
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors
11/13/2001	US6316464 P38 MAP kinase inhibitors
11/13/2001	US6316460 Containing a heptenoic acid derivative and a tribasic phosphate salt as a stabilizer; hmg-coa reductase inhibitor
11/13/2001	US6316458 Method of enhancing insulin action
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316438 Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
11/13/2001	US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors
11/13/2001	US6316413 Peptide agonists of bradykinin B2 receptor
11/13/2001	US6316403 Deactivation of factor ix for coagulation inhibition and antiischemic agents
11/13/2001	US6316219 Compounds
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316199 Arginase II
11/13/2001	US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same
11/13/2001	US6316002 Germination activated red Ganoderma lucidum spores and method for producing the same
11/13/2001	US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient
11/13/2001	US6314956 Treating lung defects associated hypoxemia or smooth muscle constriction; administer ethyl nitrite to human and monitor
11/13/2001	CA2171728C Triaryl-ethylene derivatives for use in therapy
11/08/2001	WO2001083782A2 Novel proteases
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	WO2001083746A2 Regulatory nucleic acid sequences of the abc1 gene
11/08/2001	WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001	WO2001083740A2 Splice-region antisense composition and method

1 ... 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 ... 1595